Andersen, Ditte Caroline
Bjerre, Frederik Adam
Jørgensen, Mads Gustaf
Sørensen, Jens Ahm
Jensen, Charlotte Harken https://orcid.org/0000-0001-9683-8761
Funding for this research was provided by:
Innovationsfonden (7051-00001A)
Novo Nordisk Fonden (NNF19OC0055353)
Odense Universitetshospital
Region Syddanmark
Klinisk Institut, Syddansk Universitet
Article History
Received: 3 August 2024
Accepted: 1 November 2024
First Online: 14 November 2024
Declarations
:
: In the present study, we included samples obtained during the randomized placebo controlled trial entitled “Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting” (Clinical Trial.gov ID: NCT03776721) []. The study was approved December 7th, 2018 by The Regional Committees on Health Research Ethics for Southern Denmark (S-20180117) and registered with the Danish Data Protection Agency (18/51767). All patients gave a written informed consent for participation in the study.
: The informed consent included a section regarding publication of study data and was signed by all patients.
: The authors declare no competing financial interests. The authors also declare that they have not used Artificial Intelligence in this study.